Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 34 of 44 for:    somatostatin analogues | Neuroendocrine Tumors

Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00227773
Recruitment Status : Withdrawn
First Posted : September 28, 2005
Last Update Posted : October 8, 2015
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Eastern Cooperative Oncology Group

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Primary Completion Date : No date given
  Study Completion Date : No date given